{"title":"结直肠癌的强化随访具有成本效益","authors":"Björn Ohlsson MD, PhD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.019","DOIUrl":null,"url":null,"abstract":"<div><h3>Question</h3><p>Is intensive follow-up after curative resection for colorectal cancer cost-effective compared with conventional follow-up methods?</p></div><div><h3>Study design</h3><p>Incremental cost-effectiveness analysis based on a meta-analysis of 5 RCTs.</p></div><div><h3>Main results</h3><p>Over 5 years, people having intensive follow-up gained 0.73 to 0.82 life years compared with conventional follow-up (absolute reduction in mortality with intensive follow-up: all trials 7%; 95% CI 5% to 9%; extramural trials only 9%; 95% CI 7% to 11%). Additional costs incurred by intensive follow-up were £3402 per life year gained (or £3077 based on extramural trials only). The net costs per person were £2479 and £2529, respectively.</p></div><div><h3>Authors’ conclusions</h3><p>Intensive follow-up of people with colorectal cancer is cost-effective compared to conventional methods, based on a robust economic model and efficacy evidence from 5 RCTs.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 186-187"},"PeriodicalIF":0.0000,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.019","citationCount":"0","resultStr":"{\"title\":\"Intensive follow-up for colorectal cancer is cost-effective\",\"authors\":\"Björn Ohlsson MD, PhD (Commentary Author)\",\"doi\":\"10.1016/j.ehbc.2004.05.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Question</h3><p>Is intensive follow-up after curative resection for colorectal cancer cost-effective compared with conventional follow-up methods?</p></div><div><h3>Study design</h3><p>Incremental cost-effectiveness analysis based on a meta-analysis of 5 RCTs.</p></div><div><h3>Main results</h3><p>Over 5 years, people having intensive follow-up gained 0.73 to 0.82 life years compared with conventional follow-up (absolute reduction in mortality with intensive follow-up: all trials 7%; 95% CI 5% to 9%; extramural trials only 9%; 95% CI 7% to 11%). Additional costs incurred by intensive follow-up were £3402 per life year gained (or £3077 based on extramural trials only). The net costs per person were £2479 and £2529, respectively.</p></div><div><h3>Authors’ conclusions</h3><p>Intensive follow-up of people with colorectal cancer is cost-effective compared to conventional methods, based on a robust economic model and efficacy evidence from 5 RCTs.</p></div>\",\"PeriodicalId\":100512,\"journal\":{\"name\":\"Evidence-based Healthcare\",\"volume\":\"8 4\",\"pages\":\"Pages 186-187\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.019\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based Healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1462941004000993\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1462941004000993","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Intensive follow-up for colorectal cancer is cost-effective
Question
Is intensive follow-up after curative resection for colorectal cancer cost-effective compared with conventional follow-up methods?
Study design
Incremental cost-effectiveness analysis based on a meta-analysis of 5 RCTs.
Main results
Over 5 years, people having intensive follow-up gained 0.73 to 0.82 life years compared with conventional follow-up (absolute reduction in mortality with intensive follow-up: all trials 7%; 95% CI 5% to 9%; extramural trials only 9%; 95% CI 7% to 11%). Additional costs incurred by intensive follow-up were £3402 per life year gained (or £3077 based on extramural trials only). The net costs per person were £2479 and £2529, respectively.
Authors’ conclusions
Intensive follow-up of people with colorectal cancer is cost-effective compared to conventional methods, based on a robust economic model and efficacy evidence from 5 RCTs.